Bodycote (BYPLF)
(Delayed Data from OTC)
$8.35 USD
0.00 (0.00%)
Updated Mar 18, 2024 10:57 AM ET
3-Hold of 5 3
C Value B Growth C Momentum C VGM
Cash flow Statements
Fiscal Year End for Bodycote falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 107.97 | 91.90 | 82.51 | 1.03 | 120.03 |
Depreciation/Amortization & Depletion | 102.12 | 104.27 | 115.10 | 118.00 | 107.52 |
Net Change from Assets/Liabilities | -10.70 | -64.81 | -40.57 | 23.63 | -40.86 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 38.93 | 45.39 | 41.39 | 35.95 | 40.22 |
Net Cash From Operating Activities | 238.33 | 176.75 | 198.43 | 178.60 | 226.39 |
Property & Equipment | -79.24 | -64.94 | -45.93 | -71.78 | -89.77 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | -88.69 | -85.64 | -24.39 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -9.33 | -11.63 | -9.08 | -2.31 | -1.28 |
Net Cash from Investing Activities | -88.57 | -76.56 | -143.70 | -159.73 | -115.43 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -16.42 | 0.00 | 0.00 | -0.64 | -7.66 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | -61.20 | -47.13 | 33.28 | 31.20 | -21.32 |
Payment of Dividends & Other Distributions | -50.50 | -47.62 | -67.38 | -32.23 | -95.64 |
Other Financing Activities | -8.96 | -7.67 | -7.56 | -6.42 | -5.75 |
Net Cash from Financing Activities | -137.08 | -102.42 | -41.67 | -8.09 | -130.37 |
Effect of Exchange Rate Changes | -2.11 | 0.12 | -1.10 | -0.13 | -0.13 |
Net Change In Cash & Equivalents | 10.57 | -2.10 | 11.96 | 10.66 | -19.54 |
Cash at Beginning of Period | 45.03 | 46.88 | 40.15 | 26.84 | 46.22 |
Cash at End of Period | 55.60 | 44.78 | 52.12 | 37.49 | 26.69 |
Diluted Net EPS | 0.56 | 0.48 | 0.43 | 0.00 | 0.63 |
Fiscal Year End for Bodycote falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | 107.97 | NA | 53.72 | NA |
Depreciation/Amortization & Depletion | NA | 102.12 | NA | 51.71 | NA |
Net Change from Assets/Liabilities | NA | -10.70 | NA | -8.76 | NA |
Net Cash from Discontinued Operations | NA | 0.00 | NA | NA | NA |
Other Operating Activities | NA | 38.93 | NA | 19.16 | NA |
Net Cash From Operating Activities | NA | 238.33 | NA | 115.82 | NA |
Property & Equipment | NA | -79.24 | NA | -38.82 | NA |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | NA | NA | NA |
Investments | NA | 0.00 | NA | NA | NA |
Other Investing Activities | NA | -9.33 | NA | -4.63 | NA |
Net Cash from Investing Activities | NA | -88.57 | NA | -43.45 | NA |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | -16.42 | NA | -15.28 | NA |
Issuance (Repayment) of Debt | NA | 0.00 | NA | NA | NA |
Increase (Decrease) Short-Term Debt | NA | -61.20 | NA | -27.67 | NA |
Payment of Dividends & Other Distributions | NA | -50.50 | NA | -35.68 | NA |
Other Financing Activities | NA | -8.96 | NA | -4.63 | NA |
Net Cash from Financing Activities | NA | -137.08 | NA | -83.26 | NA |
Effect of Exchange Rate Changes | NA | -2.12 | NA | -2.13 | NA |
Net Change In Cash & Equivalents | NA | 10.57 | NA | -13.02 | NA |
Cash at Beginning of Period | NA | 45.03 | NA | 45.33 | NA |
Cash at End of Period | NA | 55.60 | NA | 32.30 | NA |
Diluted Net EPS | NA | NA | NA | NA | NA |